Antibody-Based Cancer Therapy-Reference-Cited by-同舟云学术

Antibody-Based Cancer Therapy

Published:2017 Issue: Volume: Page:289-383
ISSN:1937-6448
Container-title:International Review of Cell and Molecular Biology
language:
Short-container-title:

Author:

Hendriks D.,Choi G.,de Bruyn M.,Wiersma V.R.,Bremer E.

Publisher

Elsevier

Reference453 articles.

1. Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response;Abes;Blood,2010

2. Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia;Abrisqueta;Blood,2013

3. IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients;Ahmadzadeh;Blood,2006

4. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired;Ahmadzadeh;Blood,2009

5. A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma;Ajani;Cancer J.,2000

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Analysis of Biopharmaceutical Products Listed in the FDA’s Purple Book;AAPS PharmSciTech;2024-04-18

2. Pathological Implications of Mucin Signaling in Metastasis;Current Cancer Drug Targets;2023-09

3. Scrutinizing Caesalpinia bonducella phytoactive compounds as potent regulators targeting proteins of drug instigated apoptotic and inflammatory pathways: An in-silico approach;Research Journal of Biotechnology;2023-08-15

4. Ubiquitination in Cancer Metastasis: Emerging Functions, Underlying Mechanisms, and Clinical Implications;Technology in Cancer Research & Treatment;2023-01

5. Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) in Cancer;Handbook of Cancer and Immunology;2023